Free Motion for Leave to Appear Pro Hac Vice - District Court of Delaware - Delaware


File Size: 45.2 kB
Pages: 5
Date: September 12, 2007
File Format: PDF
State: Delaware
Category: District Court of Delaware
Author: unknown
Word Count: 575 Words, 3,638 Characters
Page Size: Letter (8 1/2" x 11")
URL

https://www.findforms.com/pdf_files/ded/38286/32.pdf

Download Motion for Leave to Appear Pro Hac Vice - District Court of Delaware ( 45.2 kB)


Preview Motion for Leave to Appear Pro Hac Vice - District Court of Delaware
Case 1:07-cv-00331-SLR

Document 32

Filed 09/12/2007

Page 1 of 5

IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF DELAWARE TAKEDA PHARMACEUTICAL COMPANY LIMITED, a Japanese Corporation, TAP PHARMACEUTICAL PRODUCTS INC., a Delaware Corporation, and ETHYPHARM, S.A., a French Corporation, Plaintiffs, v. TEVA PHARMACEUTICALS USA, INC., a Delaware Corporation, and TEVA PHARMACEUTICAL INDUSTRIES LTD., an Israeli Corporation, Defendants. ) ) ) ) ) ) ) ) ) ) ) ) ) ) )

C.A. No. 07-331-SLR

MOTION FOR ADMISSION PRO HAC VICE Pursuant to Local Rule 83.5 and the attached certification, counsel moves the admission pro hac vice of James Suh of Hogan & Hartson LLP to represent plaintiffs Takeda Pharmaceutical Company Limited and Ethypharm, S.A. in this matter. In accordance with Standing Order for District Court Fund effective January 1, 2005, movant states that the annual fee of $25.00 per attorney will be submitted to the Clerks Office with this motion.

Case 1:07-cv-00331-SLR

Document 32

Filed 09/12/2007

Page 2 of 5

MORRIS, NICHOLS, ARSHT & TUNNELL LLP

/s/ Rodger D. Smith II Jack B. Blumenfeld (#1014) Mary B. Graham (#2256) Rodger D. Smith II (#3778) James W. Parrett, Jr. (#4292) 1201 N. Market Street P.O. Box 1347 Wilmington, DE 19801 (302) 658-9200 Attorneys for Plaintiffs Takeda Pharmaceutical Company Limited, TAP Pharmaceutical Products Inc., and Ethypharm, S.A. OF COUNSEL: Eric J. Lobenfeld Tedd W. Van Buskirk Arlene L. Chow Dillon Kim James Suh HOGAN & HARTSON LLP 875 Third Avenue New York, NY 10022 (212) 918-3000 Philippe Y. Riesen HOGAN & HARTSON LLP Shinjuku Center Building, 46th Floor 25-1 Nishi-Shinjuku 1-chome Shinjuku, Tokyo 163-0646 Japan (81) 3-5908-4070 Richard de Bodo HOGAN & HARTSON LLP 1999 Avenue of the Stars, Suite 1400 Los Angeles, CA 90067 (310) 785-4600 Attorneys for Plaintiffs Takeda Pharmaceutical Company Limited and Ethypharm, S.A.

Case 1:07-cv-00331-SLR

Document 32

Filed 09/12/2007

Page 3 of 5

William F. Cavanaugh Stuart E. Pollack Chad J. Peterman Patrick S. Almonrode PATTERSON BELKNAP WEBB & TYLER LLP 1133 Avenue of the Americas New York, NY 10036 (212) 336-2000 Attorneys for Plaintiff TAP Pharmaceuticals Products Inc. Paul A. Ragusa Lisa Kole BAKER BOTTS, LLP 30 Rockefeller Plaza New York, NY 10112 (212) 408-2588 Attorneys for Plaintiff Ethypharm, S.A September 12, 2007

SO ORDERED, this ___ day of ___________, 2007 ________________________________ UNITED STATES DISTRICT JUDGE

Case 1:07-cv-00331-SLR

Document 32

Filed 09/12/2007

Page 4 of 5

Case 1:07-cv-00331-SLR

Document 32

Filed 09/12/2007

Page 5 of 5

CERTIFICATE OF SERVICE I hereby certify that on September 12, 2007, I caused the foregoing to be electronically filed with the Clerk of the Court using CM/ECF, which will send electronic notification of such filing to the following: Karen L. Pascale, Esquire Karen E. Keller, Esquire YOUNG CONAWAY STARGATT & TAYLOR, LLP Additionally, I hereby certify that true and correct copies of the foregoing were caused to be served on September 12, 2007, upon the following individuals in the manner indicated: BY EMAIL: Karen L. Pascale, Esquire YOUNG CONAWAY STARGATT & TAYLOR, LLP [email protected] John L. North, Esquire SUTHERLAND ASBILL & BRENNAN LLP [email protected] Jeffrey J. Toney, Esquire SUTHERLAND ASBILL & BRENNAN LLP [email protected] Laura Fahey Fritts, Esquire SUTHERLAND ASBILL & BRENNAN LLP [email protected] Jeffrey D. Blake, Esquire SUTHERLAND ASBILL & BRENNAN LLP [email protected]

/s/ Rodger D. Smith II Rodger D. Smith II (#3778) MORRIS, NICHOLS, ARSHT & TUNNELL LLP (302) 658-9200 [email protected]